Direkt zum Inhalt

Röllig, Christoph ; Serve, Hubert ; Hüttmann, Andreas ; Noppeney, Richard ; Müller-Tidow, Carsten ; Krug, Utz ; Baldus, Claudia D ; Brandts, Christian H ; Kunzmann, Volker ; Einsele, Hermann ; Krämer, Alwin ; Schäfer-Eckart, Kerstin ; Neubauer, Andreas ; Burchert, Andreas ; Giagounidis, Aristoteles ; Krause, Stefan W ; Mackensen, Andreas ; Aulitzky, Walter ; Herbst, Regina ; Hänel, Mathias ; Kiani, Alexander ; Frickhofen, Norbert ; Kullmer, Johannes ; Kaiser, Ulrich ; Link, Hartmut ; Geer, Thomas ; Reichle, Albert ; Junghanß, Christian ; Repp, Roland ; Heits, Frank ; Dürk, Heinz ; Hase, Jana ; Klut, Ina-Maria ; Illmer, Thomas ; Bornhäuser, Martin ; Schaich, Markus ; Parmentier, Stefani ; Görner, Martin ; Thiede, Christian ; von Bonin, Malte ; Schetelig, Johannes ; Kramer, Michael ; Berdel, Wolfgang E ; Ehninger, Gerhard

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Article

Röllig, Christoph, Serve, Hubert , Hüttmann, Andreas, Noppeney, Richard, Müller-Tidow, Carsten, Krug, Utz, Baldus, Claudia D, Brandts, Christian H , Kunzmann, Volker, Einsele, Hermann, Krämer, Alwin, Schäfer-Eckart, Kerstin, Neubauer, Andreas, Burchert, Andreas, Giagounidis, Aristoteles, Krause, Stefan W , Mackensen, Andreas, Aulitzky, Walter, Herbst, Regina, Hänel, Mathias, Kiani, Alexander, Frickhofen, Norbert, Kullmer, Johannes, Kaiser, Ulrich, Link, Hartmut, Geer, Thomas, Reichle, Albert, Junghanß, Christian, Repp, Roland, Heits, Frank, Dürk, Heinz, Hase, Jana, Klut, Ina-Maria, Illmer, Thomas, Bornhäuser, Martin, Schaich, Markus, Parmentier, Stefani, Görner, Martin, Thiede, Christian , von Bonin, Malte, Schetelig, Johannes, Kramer, Michael, Berdel, Wolfgang E and Ehninger, Gerhard (2015) Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. The Lancet Oncology 16 (16), pp. 1691-1699.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleThe Lancet Oncology
PublisherELSEVIER SCIENCE INC
Place of PublicationNEW YORK
Volume16
Number of Issue or Book Chapter16
Page Rangepp. 1691-1699
Date2015
Date of publication19 Dec 2024 07:22
InstitutionsMedicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Identification Number
ValueType
10.1016/S1470-2045(15)00362-9DOI
KeywordsACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; FLT3 MUTATIONS; BONE-MARROW; COMBINATION; CHEMOTHERAPY; CYTARABINE; AML; CLASSIFICATION;
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID59911

Export bibliographical data

Owner only: item control page

nach oben